Search

… Audience This seminar is open to the research community. Tea will be served at 3:45 p.m. Location Memorial Sloan Kettering Cancer Center  Rockefeller Research Laboratories  430 East 67th Street  Room RRL-116  New York, NY 10065 Speaker(s) Arvind Pathak, Ph.D. Professor Departments of Radiology, Oncology

At the ASCO meeting in Chicago, MSK medical oncologist William Tap talked about disappointing results from a new sarcoma drug, which didn’t increase survival.

… Sunday, June 2, 2019 Summary At this year’s annual meeting of the American Society of Clinical Oncology (ASCO), MSK medical oncologist William Tap talked about disappointing results from olaratumab, a new sarcoma drug that wasn’t shown to increase survival in a recent study. At this year’s American Society

… Full Title DT2216 in Combination with Irinotecan for Children, Adolescents and Young Adults with Relapsed or Refractory Solid Tumors: A Phase I Study with Phase II Feasibility Cohort for Fibrolamellar Carcinoma (PEPN2411) (CIRB) Purpose Researchers are assessing the best dose and benefit of DT2216 given

International and national recognitions of our pioneering scientists and physician-scientists

… Memorial Sloan Kettering researchers are a distinguished group of investigators who have been recognized by national and international organizations for their work in science and medicine. Listed below are some of the prestigious awards and honors our scientists have received.

… Full Title A Phase 1b, Open-Label, Safety, Tolerability, and Efficacy Study of HC- 7366 in Combination with Belzutifan (WELIREG) or Cabozantinib (CABOMETYX) in Patients with Locally Advanced or Metastatic Renal Cell Carcinoma Purpose Researchers want to find the best dose of HC-7366 to use alone and

Memorial Sloan Kettering is one of only a few centers in the U.S. to employ liver-directed therapies – using hepatic arterial infusion (HAI) – in conjunction with a number of systemic agents.

… Wednesday, December 7, 2016 There is a real and significant need to improve clinical outcomes in patients with cholangiocarcinoma by building on first-line chemotherapy regimens and developing novel strategies for treatment in the second-line setting. Cholangiocarcinomas are rare malignancies that arise

Huperzine is extracted from Huperzia serrata, an herb used in Chinese medicine. It is marketed as a dietary supplement to improve brain function, and used as a treatment for Alzheimer’s disease and dementia in Asia.

… Common Name Chinese club moss, Huperzine; Hup A, Qian Ceng Ta, She Zu Cao, Jin Bu Huan; Shan Zhi What is it? Huperzine A may help improve memory, but studies are limited with mixed results. Huperzine A is extracted from Huperzia serrata , an herb used in Chinese medicine. It is marketed as a dietary

… Job Title Project Coordinator